Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Lifevantage Corporation (LFVN) USD0.0001

Sell:$11.60 Buy:$12.10 Change: $0.17 (1.41%)
Market closed |  Prices as at close on 22 October 2020 | Switch to live prices |
Change: $0.17 (1.41%)
Market closed |  Prices as at close on 22 October 2020 | Switch to live prices |
Change: $0.17 (1.41%)
Market closed |  Prices as at close on 22 October 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

LifeVantage Corporation is focused on bio-hacking the aging code through nutrigenomics. The Company is helping people their health, wellness and financial independence goals. The Company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim Nrf2 synergizer, Protandim NRF1 synergizer, LifeVantage TrueScience, Petandim for dogs, and Axio. It sells products in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands and Germany.

Contact details

9785 S Monroe St Ste 300
United States
+1 (801) 4329000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$171.76 million
Shares in issue:
14.24 million
Personal Products
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Garry Mauro
    Independent Chairman of the Board
  • Steven Fife
    Interim President and Chief Executive Officer, Chief Financial Officer
  • Charles Wach
    Chief Operating Officer
  • Justin Rose
    Chief Sales and Marketing Officer
  • Kevin McMurray
    General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.